Page 75 - GPD-3-1
P. 75

Gene & Protein in Disease                                        Stress-induced epigenetics of the DRD2 gene




            20 Department of Pharmaceutical Sciences, Texas Southern University College of Pharmacy and Health Sciences, Houston, TX, United
            States of America
            21 Department of Psychiatry, Case  Western Reserve University School of Medicine, Cleveland OH., 44106, USA and Department of
            Psychiatry, Mt. Sinai School of Medicine, New York, NY, United States of America
            22 Department of Child Health – Child Health Research Institute, & Department of Obstetrics, Gynecology and Women’s Health School of
            Medicine, University of Missouri, MO, United States of America
            23 Alcohol Addiction Program, Latium Region Referral Center, Sapienza University of Rome, Roma, Italy
            24 Division of Personalized Neuromodulation and Patient Care, PeakLogic, LLC, Del Mar, CA, United States of America
            25 Future Biologics, Lawrenceville, Georgia, 30043, United States of America
            26 Department of Psychology, UC San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093-0819, United States of America
            27 Department of Psychiatry, UC Riverside School of Medicine, Riverside, CA, United States of America
            28 Department of Psychiatry, Washington University School of Medicine, St. Louis, MO, United States of America




            Abstract
            The D2 dopamine receptor (DRD2) gene has garnered substantial attention as one of the most extensively studied
            genes across various neuropsychiatric disorders. Since its initial association with severe alcoholism in 1990, particularly
            through the identification of the DRD2 Taq A1 allele, numerous international investigations have been conducted to
            elucidate its role in different conditions. As of February 22, 2024, there are 5485 articles focusing on the DRD2 gene
            listed in PUBMED. There have been 120 meta-analyses with mixed results. In our opinion, the primary cause of negative
            reports regarding the association of various DRD2 gene polymorphisms is the inadequate screening of controls, not
            adequately eliminating many hidden reward deficiency syndrome behaviors. Moreover, pleiotropic effects of DRD2
            variants have been identified in neuropsychologic, neurophysiologic, stress response, social stress defeat, maternal
            deprivation, and gambling disorder, with epigenetic DNA methylation and histone post-translational negative
            methylation identified as discussed in this article. There are 70 articles listed in PUBMED for DNA methylation and 20
            articles listed for histone methylation as of October 19, 2022. For this commentary, we did not denote DNA and/or
            histone methylation; instead, we provided a brief summary based on behavioral effects. Based on the fact that Blum
            and Noble characterized the DRD2 Taq A1 allele as a generalized reward gene and not necessarily specific alcoholism,
            it now behooves the field to find ways to either use effector moieties to edit the neuroepigenetic insults or possibly
            harness the idea of potentially removing negative mRNA-reduced expression by inducing “dopamine homeostasis.”

            Keywords: Dopamine D2 receptor; Epigenetic modification; Neurological disorders; Stress




            1. Introduction                                    prevention (CDC)  reported 106,699  overdose  deaths  in
                                                               the US, with 80,441 of those deaths related to opioids. In
            In 2013, Blum’s research team initiated an inquiry into   addition, provisional data from the CDC indicated that
            the  motivations  behind alcohol consumption and  high   opioid deaths in 2022 would rise to approximately 82,998. 7,8
            rates of drug-seeking behaviors, particularly in response
            to stressful situations.  Their goal was to raise awareness   Blum et al. established the concept of reward deficiency
                             1-4
            and understanding of the underlying mechanisms driving   syndrome (RDS) in 1995 as a potential predictor of
            such behaviors. Moreover, they posed additional questions   addictive and impulsive behaviors. 5,9-11  This theory has
            regarding the millions of individuals who seek out and   since been supported by numerous studies, indicating
            engage in high-risk novelty  situations,  pondering  the   that behavioral, cognitive, and emotional disturbances
            consequences of pleasure-seeking behaviors. They   observed in psychiatric disorders, including RDS, are
            suggested that  the  answers  to these questions  may lie   linked to functional deficits in neurological pathways. 12-17
            within the intricate workings of our brains and perhaps   For instance, the D2 dopamine receptor (DRD2) Taq
            within our genetic makeup. 5,6                     A1  allele has been consistently associated with numerous
              America is currently facing the worst opioid epidemic   behavioral phenotypes, including aggression,  alcoholism,
                                                                                                   18
            in history. In 2021, the centers for disease control and   addictive behaviors,  and neuropsychiatric disorders. Both
                                                                              19
            Volume 3 Issue 1 (2024)                         2                        https://doi.org/10.36922/gpd.1966
   70   71   72   73   74   75   76   77   78   79   80